You Love Dogs? Then Don’t Clone Them
By Jessica Pierce,
New York Times
| 03. 06. 2018
Why, people want to know, did Barbra Streisand decide to clone Samantha, her coton de tulear? What would compel someone to spend $50,000 or more to create a genetic replica of a pet dog?
In the recent buzz over pet cloning, the issue has largely been framed as a personal decision, albeit a quirky one. But the decision to clone is not merely personal. There are broader ramifications for dogs, not only for the large group of dogs we call pets but also for a whole canine underclass that remains largely invisible to us but whose bodies serve as a biological substrate for cloning research and industry.
Clones like Ms. Streisand’s dogs Miss Violet and Miss Scarlett don’t materialize out of thin air but require the help of a whole team of female dogs. The cloning process begins with a group of dogs that will “donate” their eggs, a process that involves pharmaceutical manipulation of hormone levels and a surgical egg-harvesting procedure. Once removed from the donor dogs’ ovaries, the eggs will be enucleated — the unwanted DNA from the...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...